Talk to the Institute
Published mark

Annexon, Inc.

NASDAQ: ANNX. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:c1f8f562-952b-4849-bcc2-7de87224b266
SEC CIK
0001528115
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 17, 2026
Newest evidence
May 3, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Douglas LoveSince Apr 27, 2026
Chair
Not published
Independent
7 / 88 directors published
Published claims
334 distinct sources
Evidence records
140 pinned
Source conflicts
0None open

Built from 4 distinct sources and 14 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

CEO CHANGED

Douglas Love executive of Annexon, Inc., effective 2026-04-27.

EffectiveEffective Apr 27, 2026E4

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
President, Chief Executive Officer and Class III DirectorDouglas LoveApr 2026currentSource reportedE4
EVP Chief Medical OfficerJamie DananbergApr 2026currentSource reportedE5
EVP Chief Financial OfficerJennifer LewApr 2026currentSource reportedE7
EVP Chief Business OfficerMichael OverdorfApr 2026currentSource reportedE8
EVP Chief Scientific OfficerRick ArtisApr 2026currentSource reportedE10
EVP Chief Innovation OfficerTed YednockApr 2026currentSource reportedE12
President, Chief Executive Officer and Class III DirectorDouglas E. Love, Esq.Not capturedunknownSource reportedE3
EVP Chief Medical OfficerJamie Dananberg, M.D.Not capturedunknownSource reportedE6
EVP Chief Business OfficerMichael Overdorf, M.B.A.Not capturedunknownSource reportedE9
EVP Chief Scientific OfficerRick Artis, Ph.D.Not capturedunknownSource reportedE11
EVP Chief Innovation OfficerTed Yednock, Ph.D.Not capturedunknownSource reportedE13

Board of directors

Evidence

8 directors published. 7 of 8 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Bettina M. Cockroft, M.D.Independent2022None publishedSource reportedE2
Douglas E. LoveNot independent2014None publishedSource reportedE2
Jung E. ChoiIndependent2020Compensation, chairCompensation · ChairSource reportedE2
Muneer A. SatterIndependent2014AuditAudit; Nominating and Governance · ChairNominating and Governance, chairSource reportedE2
Thomas G. WiggansIndependent2017CompensationCompensation; Nominating and GovernanceNominating and GovernanceSource reportedE2
William (BJ) Jones, Jr.Independent2025None publishedSource reportedE2
William D. WaddillIndependent2021Audit, chairAudit · Chair; Nominating and GovernanceNominating and GovernanceSource reportedE2
William H. Carson, M.D.Independent2021None publishedSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditWilliam D. WaddillWilliam D. Waddill, Muneer A. SatterNot described in the published record
Audit · Chair; Nominating and GovernanceNot publishedWilliam D. WaddillNot described in the published record
Audit; Nominating and Governance · ChairNot publishedMuneer A. SatterNot described in the published record
CompensationJung E. ChoiJung E. Choi, Thomas G. WiggansNot described in the published record
Compensation · ChairNot publishedJung E. ChoiNot described in the published record
Compensation; Nominating and GovernanceNot publishedThomas G. WiggansNot described in the published record
Nominating and GovernanceMuneer A. SatterMuneer A. Satter, Thomas G. Wiggans, William D. WaddillNot described in the published record
Committee RecordAudit: Chair William D. Waddill; Members William D. Waddill (Chair); Muneer A. Satter
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_record:24
Committee AppointmentWilliam D. Waddill: chair, Audit
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:25
Committee AppointmentMuneer A. Satter: member, Audit
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:26
Committee RecordCompensation: Chair Jung E. Choi; Members Jung E. Choi (Chair); Thomas G. Wiggans
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_record:27
Committee AppointmentJung E. Choi: chair, Compensation
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:28
Committee AppointmentThomas G. Wiggans: member, Compensation
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:29
Committee RecordNominating and Governance: Chair Muneer A. Satter; Members Muneer A. Satter (Chair); Thomas G. Wiggans; William D. Waddill
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_record:30
Committee AppointmentMuneer A. Satter: chair, Nominating and Governance
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:31
Committee AppointmentThomas G. Wiggans: member, Nominating and Governance
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:32
Committee AppointmentWilliam D. Waddill: member, Nominating and Governance
Source reportedE14
company:c1f8f562-952b-4849-bcc2-7de87224b266:committee_appointment:33

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerDouglas Love, President, Chief Executive Officer and Class III Director, from Apr 27, 2026
Source reportedE4
company:c1f8f562-952b-4849-bcc2-7de87224b266:leadership_role:14
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingANNX (NASDAQ)
Source reportedE1
company:c1f8f562-952b-4849-bcc2-7de87224b266:security_listing:34
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 17, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameAnnexon, Inc.
Source reportedE1
company:c1f8f562-952b-4849-bcc2-7de87224b266:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:c1f8f562-952b-4849-bcc2-7de87224b266:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
14 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 17, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Annexon, Inc. DEF 14A 2025-04-23
    sec proxy. Published Apr 23, 2025. Retrieved Apr 24, 2026. Cited by 8 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    ANNX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    ANNX DEF 14A executive officers
    sec filing. Published Apr 27, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    ANNX DEF 14A executive officers
    sec filing. Published Apr 27, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    ANNX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    ANNX DEF 14A executive officers
    sec filing. Published Apr 27, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    ANNX DEF 14A executive officers
    sec filing. Published Apr 27, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    ANNX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    ANNX DEF 14A executive officers
    sec filing. Published Apr 27, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    ANNX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    ANNX DEF 14A executive officers
    sec filing. Published Apr 27, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    ANNX executive roster source
    sec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
    Authority not assessed
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    Audit
    board_seats. board seats. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 17, 2026
  • Douglas Love executive of Annexon, Inc., effective 2026-04-27.
  • Jamie Dananberg executive of Annexon, Inc., effective 2026-04-27.
  • Jennifer Lew executive of Annexon, Inc., effective 2026-04-27.
  • Michael Overdorf executive of Annexon, Inc., effective 2026-04-27.
  • Rick Artis executive of Annexon, Inc., effective 2026-04-27.
  • Ted Yednock executive of Annexon, Inc., effective 2026-04-27.
  • William (BJ) Jones, Jr. seat on Annexon, Inc., effective 2025-01-01.
  • Bettina M. Cockroft, M.D. seat on Annexon, Inc., effective 2022-01-01.
  • William D. Waddill seat on Annexon, Inc., effective 2021-01-01.
  • William H. Carson, M.D. seat on Annexon, Inc., effective 2021-01-01.
  • Audit · Chair; Nominating and Governance committee of Annexon, Inc., effective 2021-01-01.
  • William D. Waddill member of Audit · Chair; Nominating and Governance, effective 2021-01-01.
  • Jung E. Choi seat on Annexon, Inc., effective 2020-01-01.
  • Compensation · Chair committee of Annexon, Inc., effective 2020-01-01.
  • Jung E. Choi member of Compensation · Chair, effective 2020-01-01.
  • Thomas G. Wiggans seat on Annexon, Inc., effective 2017-01-01.
  • Compensation; Nominating and Governance committee of Annexon, Inc., effective 2017-01-01.
  • Thomas G. Wiggans member of Compensation; Nominating and Governance, effective 2017-01-01.
  • Douglas E. Love seat on Annexon, Inc., effective 2014-01-01.
  • Muneer A. Satter seat on Annexon, Inc., effective 2014-01-01.
  • Audit; Nominating and Governance · Chair committee of Annexon, Inc., effective 2014-01-01.
  • Muneer A. Satter member of Audit; Nominating and Governance · Chair, effective 2014-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:c1f8f562-952b-4849-bcc2-7de87224b266, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/annexon-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership11
  4. Board8
  5. Committees7
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people19
  17. Subject and corrections6
  18. Evidence14
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:c1f8f562-952b-4849-bcc2-7de87224b266
  • Cite this recordAnnexon, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/annexon-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Annexon, Inc.Company
  • Douglas LovePerson
  • Jamie DananbergPerson
  • Jennifer LewPerson
  • Michael OverdorfPerson
  • Rick ArtisPerson
  • Ted YednockPerson
  • Douglas E. Love, Esq.Person
  • Jamie Dananberg, M.D.Person
  • Michael Overdorf, M.B.A.Person
  • Rick Artis, Ph.D.Person
  • Ted Yednock, Ph.D.Person
  • Bettina M. Cockroft, M.D.Person
  • Douglas E. LovePerson
  • Jung E. ChoiPerson
  • Muneer A. SatterPerson
  • Thomas G. WiggansPerson
  • William (BJ) Jones, Jr.Person
  • William D. WaddillPerson
  • William H. Carson, M.D.Person
  • Sections
    OverviewAnnexon, Inc.
  • MonitoringAnnexon, Inc.
  • LeadershipAnnexon, Inc.
  • BoardAnnexon, Inc.
  • CommitteesAnnexon, Inc.
  • Control and votingAnnexon, Inc.
  • Authority to actAnnexon, Inc.
  • FinancialsAnnexon, Inc.
  • GovernanceAnnexon, Inc.
  • RiskAnnexon, Inc.
  • AI oversightAnnexon, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.